Nancy Ferro: Master of Fine Arts Thesis Exhibition Show Card

Show Card for Nancy Ferro: Print and Drawings. Thesis exhibition for MFA.https://digitalcommons.udallas.edu/mfa_87-88/1004/thumbnail.jp

Nancy Johnston Ferro: Master of Arts Thesis Exhibition Show Card

Master of Arts Thesis Exhibition for Nancy Johnston Ferro. February 24 - March 9, 1985.https://digitalcommons.udallas.edu/ma_85-86/1004/thumbnail.jp

4: Recent Works Show Card

Show card featuring Alumni Nancy Ferro.https://digitalcommons.udallas.edu/alumni_89-90/1001/thumbnail.jp

Evaluation of cosmetic results of the nasal ala, dorsum and tip of the nose in treatments with SENSUS SRT-100TM

Introducción: el cáncer de piel no melanoma (NMSC) es el cáncer más común en humanos. La cirugía en estos pacientes ha sido considerada el “gold standard”, pero puede no ser la opción apropiada, especialmente en áreas donde la misma pueda provocar morbilidades funcionales o cosméticas por pérdida de tejido.Objetivo: evaluar los resultados cosméticos en pacientes con carcinomas de piel en las localizaciones de ala nasal, dorso y/o punta de la nariz tratados con radioterapia superficial.Métodos: se realizó un estudio observacional, longitudinal, retrospectivo en pacientes con carcinoma de piel tratados con radioterapia superficial con SENSUS SRT-100 TM efectuados durante el período septiembre de 2017 hasta diciembre de 2021 en Pinar del Río. El universo estuvo constituido por 34 pacientes, la muestra por 28, obtenida mediante muestreo intencional no probabilístico según los criterios de inclusión y exclusión establecidos.  Resultados: el promedio de edad registrado fue en mayores de 60 años, género masculino, color de la piel blanco y como tipo histológico predominante, el carcinoma de células basales. Se utilizaron esquemas de fraccionamiento convencional en más del 70 % de los casos. Los efectos adversos tardíos más frecuentes fueron la atrofia ligera del cartílago nasal y la hipo pigmentación de la piel, clasificado como grado de toxicidad 0/1 vinculado a un resultado cosmético excelente/bueno en el 89,7 %.  Conclusiones: los resultados cosméticos obtenidos fueron considerados como excelente/bueno, reportando bajo perfil de toxicidad y bajas tasas de recurrencia local, demostrándose seguridad y calidad mediante el empleo de la radioterapia superficial como opción de tratamiento en pacientes con carcinomas de piel.Introduction: non-melanoma skin cancer (NMSC) is the most common cancer in humans. Surgery in these patients has been considered the "gold standard", but it may not be the appropriate option, especially in areas where it may cause functional or cosmetic morbidities due to tissue loss.Objective: To evaluate cosmetic outcomes in patients with skin carcinomas in the nasal ala, dorsum and/or tip of the nose treated with surface radiotherapy.Methods: an observational, longitudinal, retrospective study was conducted in patients with skin carcinoma treated with superficial radiotherapy with SENSUS SRT-100 TM during the period September 2017 to December 2021 in Pinar del Río. The universe consisted of 34 patients, the sample consisted of 28, obtained by non-probabilistic purposive sampling according to the established inclusion and exclusion criteria.Results: the average age recorded was over 60 years, male gender, skin colour white and the predominant histological type was basal cell carcinoma. Conventional fractionation schedules were used in more than 70 % of cases. The most frequent late adverse effects were mild atrophy of the nasal cartilage and hypopigmentation of the skin, classified as toxicity grade 0/1 linked to an excellent/good cosmetic outcome in 89,7 %.Conclusions: The cosmetic results obtained were considered excellent/good, reporting low toxicity profile and low local recurrence rates, demonstrating safety and quality through the use of surface radiotherapy as a treatment option in patients with skin carcinomas

Gastric emptying of low- and high-caloric liquid meals measured using ultrasonography in healthy volunteers

Purpose Delayed gastric emptying is present in patients with functional dyspepsia (FD), diabetes mellitus, and neurological diseases. Diet may affect gastric emptying symptoms in patients with FD. We sought to determine the extent to which gastric emptying and symptoms of dyspepsia are influenced by caloric content in healthy subjects using ultrasonography. Materials and Methods 32 healthy volunteers were given 2 meals with different caloric content in random order. Gastric emptying was determined using ultrasonography to measure antral area when fasting, and postprandially at intervals of 0, 10, 20, and 30 min. Dyspeptic symptoms including discomfort, nausea, and fullness were graded. Results The antral area following a high-caloric meal compared to a low-caloric meal was significantly increased at 0, 10, 20, and 30 min (P=0.0203,<0.0001<0.0001,<0.0001, respectively), as was the median fullness (P<0.0048, 0.0001, 0.0009, 0.0001, respectively) measured at the same time points. There was a weak correlation (r2=0.1, P<0.0001) between the antral area and subjective fullness. No differences between gastric emptying in males and females were found. Conclusion The caloric content of a meal influences gastric emptying. Using ultrasonography to measure the antral area helps us to assess gastric emptying and therefore to assess patients with functional dyspepsia.publishedVersio

La Universidad y la comunidad educativa en contextos de diversidad lingüística y cultural: experiencias formativas en escuelas del sur de la Ciudad de Buenos Aires

En el marco del UBANEX Multilingüismo en el aula. Diversidad lingüística e inclusión educativa en escuelas públicas de los barrios de Barracas, Nueva Pompeya, Flores y Once de la Ciudad de Buenos Aires (Segunda Parte), el presente trabajo se propone desarrollar las experiencias que se llevan a cabo en conjunto con la Escuela Primaria N°10 D. E. 5 Deán Estanislao de Zavaleta en el barrio de Barracas. Las actividades que se realizan forman parte de las acciones participativas que involucran a la comunidad y al equipo universitario en torno a la diversidad lingüística y cultural. De acuerdo con los datos de la Unidad de Evaluación Integral de la Calidad y Equidad Educativa del GCBA, la población escolar de la zona sur de la Ciudad Autónoma de Buenos Aires está constituida, en un porcentaje significativo, por hogares de familias migrantes donde se presenta un entramado heterogéneo vinculado a la presencia de más de una lengua/s y cultura/s. En el caso de la Escuela N°10 D.E. 5, las alumnas y alumnos que asisten provienen de familias argentinas, paraguayas y, en menor cantidad, bolivianas y peruanas. Esta composición poblacional permite visibilizar la heterogeneidad lingüística y cultural vinculada a la presencia vital de lengua/s materna/s diferentes del español; al uso familiar y comunitario, cotidiano y extendido, de lenguas originarias: el guaraní, el quechua y aymara. Es por esto que las actividades que se llevan a cabo buscan contribuir en distintos aspectos, a saber: 1) El reconocimiento de la escuela como un ámbito plurilingüe, legitimando la coexistencia de lenguas y culturas. 2) El cuestionamiento a la ideología lingüística hegemónica, que promueve de supremacía del español y su carácter homogeneizador. 3) La garantía del acceso a conocimientos, prácticas y experiencias interculturales. 4) El fortalecimiento de los lazos y el intercambio de saberes entre padres, maestros y estudiantes. Asimismo, se busca, a partir del proyecto, generar un espacio que permita formar a las y los estudiantes universitarios en prácticas comunitarias en el marco de contextos bi/multilingües e interculturales. En suma, estas acciones permiten analizar la relevancia de trabajar con las comunidades educativas, aportando a la visibilización de la heterogeneidad lingüística y cultural.GT75: Experiencias formativas en contextos de desigualdad y diversidad sociocultural.Universidad Nacional de La Plat

A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients

Desmopressin (dDAVP) is a well-known peptide analog of the antidiuretic hormone vasopressin, used to prevent excessive bleeding during surgical procedures. dDAVP increases hemostatic mediators, such as the von Willebrand factor (vWF), recently considered a key element in resistance to metastasis. Studies in mouse models and veterinary trials in dogs with locally-advanced mammary tumors demonstrated that high doses of perioperative dDAVP inhibited lymph node and early blood-borne metastasis and significantly prolonged survival. We conducted a phase II dose-escalation trial in patients with breast cancer, administering a lyophilized formulation of dDAVP by intravenous infusion in saline, 30–60 min before and 24 h after surgical resection. Primary endpoints were safety and tolerability, as well as selection of the best dose for cancer surgery. Secondary endpoints included surgical bleeding, plasma levels of vWF, and circulating tumor cells (CTCs) as measured by quantitative PCR of cytokeratin-19 transcripts. Only 2 of a total of 20 patients experienced reversible adverse events, including hyponatremia (grade 4) and hypersensitivity reaction (grade 2). Reactions were adequately managed by slowing the infusion rate. A reduced intraoperative bleeding was noted with increasing doses of dDAVP. Treatment was associated with higher vWF plasma levels and a postoperative drop in CTC counts. At the highest dose level evaluated (2 μg/kg) dDAVP appeared safe when administered in two slow infusions of 1 μg/kg, before and after surgery. Clinical trials to establish the effectiveness of adjunctive perioperative dDAVP therapy are warranted. This trial is registered on www.clinicaltrials.gov (NCT01606072).Fil: Weinberg, Ruth S.. Provincia de Buenos Aires. Ministerio de Salud. Hospital Interzonal de Agudos "Eva Perón"; ArgentinaFil: Grecco, Marcelo O.. Provincia de Buenos Aires. Ministerio de Salud. Hospital Interzonal de Agudos "Eva Perón"; ArgentinaFil: Ferro, Gimena S.. Provincia de Buenos Aires. Ministerio de Salud. Hospital Interzonal de Agudos "Eva Perón"; ArgentinaFil: Seigelshifer, Debora Judith. Provincia de Buenos Aires. Ministerio de Salud. Hospital Interzonal de Agudos "Eva Perón"; ArgentinaFil: Perroni, Nancy V.. Provincia de Buenos Aires. Ministerio de Salud. Hospital Interzonal de Agudos "Eva Perón"; ArgentinaFil: Terrier, Francisco J.. Instituto Universitario del Hospital Italiano de Buenos Aires; ArgentinaFil: Sánchez Luceros, Analía Gabriela. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina. Academia Nacional de Medicina de Buenos Aires; ArgentinaFil: Maronna, Esteban. Centro de Educación Médica e Investigaciones Clínicas “Norberto Quirno”; ArgentinaFil: Sánchez Marull, Ricardo. Centro de Educación Médica e Investigaciones Clínicas “Norberto Quirno”; ArgentinaFil: Frahm, Isabel. Centro de Educación Médica e Investigaciones Clínicas “Norberto Quirno”; ArgentinaFil: Guthmann, Marcelo D.. Laboratorio Elea; ArgentinaFil: Di Leo, Daniela. Laboratorio Elea; ArgentinaFil: Spitzer, Eduardo. Laboratorio Elea; ArgentinaFil: Ciccia, Graciela Noemi. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Garona, Juan. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Quilmes; ArgentinaFil: Pifano, Marina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Quilmes; ArgentinaFil: Torbidoni, Ana Vanesa. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Quilmes; ArgentinaFil: Gomez, Daniel Eduardo. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Quilmes; ArgentinaFil: Ripoll, Giselle Vanina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Quilmes; ArgentinaFil: Gomez, Roberto E.. Laboratorio Elea; ArgentinaFil: Demarco, Ignacio A.. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Alonso, Daniel Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Quilmes; Argentin

A phase II dose‑escalation trial of perioperative desmopressin (1‑desamino‑8‑D‑arginine vasopressin) in breast cancer patients

Desmopressin (dDAVP) is a well-known peptide analog of the antidiuretic hormone vasopressin, used to prevent excessive bleeding during surgical procedures. dDAVP increases hemostatic mediators, such as the von Willebrand factor (vWF), recently considered a key element in resistance to metastasis. Studies in mouse models and veterinary trials in dogs with locally-advanced mammary tumors demonstrated that high doses of perioperative dDAVP inhibited lymph node and early blood-borne metastasis and significantly prolonged survival. We conducted a phase II dose-escalation trial in patients with breast cancer, administering a lyophilized formulation of dDAVP by intravenous infusion in saline, 30–60 min before and 24 h after surgical resection. Primary endpoints were safety and tolerability, as well as selection of the best dose for cancer surgery. Secondary endpoints included surgical bleeding, plasma levels of vWF, and circulating tumor cells (CTCs) as measured by quantitative PCR of cytokeratin-19 transcripts. Only 2 of a total of 20 patients experienced reversible adverse events, including hyponatremia (grade 4) and hypersensitivity reaction (grade 2). Reactions were adequately managed by slowing the infusion rate. A reduced intraoperative bleeding was noted with increasing doses of dDAVP. Treatment was associated with higher vWF plasma levels and a postoperative drop in CTC counts. At the highest dose level evaluated (2 μg/kg) dDAVP appeared safe when administered in two slow infusions of 1 μg/kg, before and after surgery. Clinical trials to establish the effectiveness of adjunctive perioperative dDAVP therapy are warranted. This trial is registered on www.clinicaltrials.gov (NCT01606072).Facultad de Ciencias Médica

Differential cross section measurements for the production of a W boson in association with jets in proton–proton collisions at √s = 7 TeV

Measurements are reported of differential cross sections for the production of a W boson, which decays into a muon and a neutrino, in association with jets, as a function of several variables, including the transverse momenta (pT) and pseudorapidities of the four leading jets, the scalar sum of jet transverse momenta (HT), and the difference in azimuthal angle between the directions of each jet and the muon. The data sample of pp collisions at a centre-of-mass energy of 7 TeV was collected with the CMS detector at the LHC and corresponds to an integrated luminosity of 5.0 fb[superscript −1]. The measured cross sections are compared to predictions from Monte Carlo generators, MadGraph + pythia and sherpa, and to next-to-leading-order calculations from BlackHat + sherpa. The differential cross sections are found to be in agreement with the predictions, apart from the pT distributions of the leading jets at high pT values, the distributions of the HT at high-HT and low jet multiplicity, and the distribution of the difference in azimuthal angle between the leading jet and the muon at low values.United States. Dept. of EnergyNational Science Foundation (U.S.)Alfred P. Sloan Foundatio